Related Experiment Video
Updated: Apr 16, 2026

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Giant neglected squamous cell carcinoma of the skin
Francesco Ricci1, Andrea Paradisi2, Barbara Fossati1
1Department of Dermatology, Catholic University of Sacred Heart, Rome, Italy.
Abstract:
Nonmelanoma skin cancers (NMSCs) are the most common type of skin tumor, representing about one-third of all malignancies diagnosed worldwide each year. Cutaneous squamous cell carcinoma (cSCC) is the second most common form of NMSCs and the risk of cSCC invasiveness should be assessed on the basis of tumor size, anatomical location, and histological subtype. Although most cSCCs are early diagnosed and successfully treated, in a small percentage of patients with giant cSCC (maximum diameter >5 cm), metastases may occur; treatment options are limited and not really effective. We report the case of a giant metastatic cSCC that had been neglected for more than 20 years. Radiotherapy or surgery were not feasible and polichemotherapy (cisplatin, 5-fluorouracil and paclitaxel) was not effective. Therefore, the patient was treated with palliative electrochemotherapy (ECT) achieving a partial reduction of cutaneous metastasis and pain relief but unfortunately the patient died 3 months after the second ECT treatment.
Insights
Giant metastatic cutaneous squamous cell carcinoma (cSCC) is rare but challenging to treat. This case highlights limited options and the palliative use of electrochemotherapy (ECT) for neglected, advanced skin cancer.
Area of Science:
- Oncology
- Dermatology
- Cancer Research
Background:
- Nonmelanoma skin cancers (NMSCs) are the most common malignancies globally.
- Cutaneous squamous cell carcinoma (cSCC) is the second most frequent NMSC.
- Assessing cSCC invasiveness relies on tumor size, location, and histology.
Observation:
- Giant cSCC (>5 cm) can metastasize, posing treatment challenges.
- A case of a neglected giant metastatic cSCC over 20 years is presented.
- Standard treatments like radiotherapy, surgery, and polychemotherapy were ineffective.
Findings:
- Palliative electrochemotherapy (ECT) was administered to the patient.
- ECT resulted in partial reduction of cutaneous metastasis and pain relief.
- The patient unfortunately passed away 3 months after the second ECT treatment.
Implications:
- This case underscores the limited therapeutic options for advanced, neglected cSCC.
- Electrochemotherapy (ECT) may offer palliative benefits in select metastatic skin cancer cases.
- Further research is needed for effective treatments for giant and metastatic cSCC.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Accessory Structures of the Skin: Sebaceous Glands
These glands that produce the oils on the skin and hair are holocrine glands. The mature...
Renewal of Skin Epidermal Stem Cells
Abnormal Proliferation
